- Teleflex Publishes 2023 Global Impact Report
- Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
- Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
- Teleflex Announces Quarterly Dividend
- Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
- Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
- Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
- Teleflex to Present at the BofA Securities 2024 Health Care Conference
- Teleflex Announces First Quarter 2024 Earnings Conference Call Information
- Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
More ▼
Key statistics
On Monday, Teleflex Inc (TFX:NYQ) closed at 207.09, 16.58% above the 52 week low of 177.63 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 211.08 |
---|---|
High | 211.19 |
Low | 203.13 |
Bid | 195.00 |
Offer | 251.00 |
Previous close | 212.57 |
Average volume | 644.34k |
---|---|
Shares outstanding | 47.10m |
Free float | 46.98m |
P/E (TTM) | 34.59 |
Market cap | 10.19bn USD |
EPS (TTM) | 6.26 USD |
Annual div (ADY) | 1.36 USD |
---|---|
Annual div yield (ADY) | 0.64% |
Div ex-date | May 14 2024 |
Div pay-date | Jun 14 2024 |
Data delayed at least 15 minutes, as of Jun 10 2024 21:10 BST.
More ▼